Skip to Content
COVID-19 Resources
Cancer Imaging Program (CIP)
Contact CIP
Show menu
Search this site
Last Updated: 10/28/16

Newsletter No. 1 — April, 1998

The Diagnostic Imaging Program at NCI is creating this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. We will use this mechanism sparingly, and primarily to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on this list, no action is necessary.

If you wish to be removed from the list, or add or substitute someone else in your organization, please contact Johnnie Smith by return e-mail (


    This is R21 funding and includes the words "Applications involving computational approaches to such areas as imaging, data analysis, modeling, etc. must emphasize algorithm development. Computational approaches applied to drug discovery are appropriate to this announcement only if they clearly move beyond currently utilized computational, structure-based, and combinatorial approaches."
    The Cancer Therapy Evaluation Program (CTEP) of the Division of Cancer Treatment and Diagnosis (DCTD) at the National Cancer Institute (NCI) invites applications for cooperative agreements (U01) from institutions to participate in establishing a multidisciplinary network of highly specialized investigators to efficiently evaluate technically challenging and innovative treatment approaches for children with brain tumors. This Pediatric Brain Tumor Clinical Trials Consortium (PBTCTC) will conceive, develop, and conduct collaborative Pilot and Phase I and II clinical evaluations of promising new therapeutic agents or approaches for the treatment of primary central nervous system (CNS) malignancies in pediatric patients. The Consortium will consist of up to 8 Participant Member Institutions selected by peer review for their documented ability to develop and conduct clinical trials of innovative treatment approaches and for their multidisciplinary expertise in supporting innovative brain tumor clinical research.
  3. NEUROSCIENCES TECHNOLOGY DEVELOPMENT (PA-98-050)/NOA - NIH Application Receipt Dates: June 1, October 1, and February 1
    The purpose of this Program Announcement (PA) is to encourage submission of new research project grant (R01) and exploratory/developmental research grant (R21) applications to develop innovative technologies.
  4. Matching Keywords : Medical & Diagnostic Imaging, Medical Informatics, Neurological Disorders, Neuroscience
  5. FULL-TIME BRANCH CHIEF positions are available in the Diagnostic Imaging Program for individuals with an MD or PhD background. See advertisements in the February or March issues of Radiology (page 81A) or Academic Radiology

The staff of the Diagnostic Imaging Program places a high priority on communicating with and facilitating the work of researchers in the imaging community. We look forward to working with you.

Daniel Sullivan M.D.